Condition
Anthracycline-induced Cardiac Toxicity clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Anthracycline-induced Cardiac Toxicity clinical trials that are recruiting, at sites in 7 countries (most in Denmark (1), France (1), Germany (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 7Countries
All recruiting trials (2)
-
Dapagliflozin to prevent chemotherapy-related heart damage in breast cancer
We will test if taking dapagliflozin 10 mg daily prevents heart and blood-vessel damage in adult women receiving anthracycline chemotherapy for breast cancer.
-
Remote Ischemic Conditioning for Lymphoma Patients Receiving Chemotherapy
This study is testing if a special treatment called Remote Ischemic Preconditioning can help protect the hearts of lymphoma patients from damage while they receive chemotherapy.
Related topics
Quick answers
How many Anthracycline-induced Cardiac Toxicity clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Denmark (1 trial), France (1 trial), Germany (1 trial), Netherlands (1 trial), Portugal (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.